BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4948561)

  • 1. [Clinical study and effect on the uterine receptor of the combination Norgestrel-Ethinyl-Estradiol (FH 122-A) in 500 menstrual cycles].
    Lévrier M
    Bord Med; 1970 Jan; 3(1):225-6. PubMed ID: 4948561
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral-cytological studies on the effect of combined contraceptive preparations as compared to menstruation and pregnancy].
    Zellner P; Klinger G
    Stomatol DDR; 1982 Oct; 32(10):673-7. PubMed ID: 6190274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical studies on the low-dosage norgestrel-ethinylestradiol combination as a long term oral contraception (author's transl)].
    Higashiyama S; Obata T; Kizu S; Nakano Y; Iwasaki T
    Nihon Funin Gakkai Zasshi; 1974 Jan; 19(1):40-53. PubMed ID: 4478810
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic effects of a combination of dl-norgestrel and ethinylestradiol in humans.
    Gerhards E; Lachnit U; Gaude R; Schillinger E
    Arzneimittelforschung; 1973 Jun; 23(6):779-84. PubMed ID: 4740760
    [No Abstract]   [Full Text] [Related]  

  • 6. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Kluft C
    Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of norgestrel-ethinyl oestradiol as a contraceptive.
    Tyler ET; Matsner EM; Gotlib MH; Levin M; Daniels T; Shimabukuro B; Dolman H; Elliot J
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:109-16. PubMed ID: 5288229
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of an oral contraceptive on serum phosphohexose isomerase activity.
    Gupta U; Khuteta KP; Gupta RC
    Indian J Physiol Pharmacol; 1983; 27(3):253-4. PubMed ID: 6668056
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of norgestrel in combination with ethinyl oestradiol on the human pituitary-adrenal axis.
    Givens JR; Fort AT; Leigh JH
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:69-76. PubMed ID: 4330931
    [No Abstract]   [Full Text] [Related]  

  • 10. Central and peripheral parameters of the menstrual cycle under the influence of a new combined oral contraceptive.
    Spona J; Schneider WH
    Acta Obstet Gynecol Scand Suppl; 1976; 54():45-50. PubMed ID: 788444
    [No Abstract]   [Full Text] [Related]  

  • 11. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.
    Cullberg J
    Acta Psychiatr Scand Suppl; 1972; 236():1-86. PubMed ID: 4565340
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative studies of two oral contraceptives containing DL norgestrel and D norgestrel.
    Koetsawang S; Rimdusit S; Srivanaboon S; Bhiraleus P; Rachawat D
    J Med Assoc Thai; 1973 May; 56(5):314-8. PubMed ID: 4783789
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical studies on the SH 1000 as oral contraception (author's transl)].
    Takayanagi M; Kamada M; Kushiki N; Lyo K; Fujiwara M
    Nihon Funin Gakkai Zasshi; 1974 Oct; 19(4):36-45. PubMed ID: 4478828
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinolytic activity of uterine fluid in oral contraceptive users.
    Casslén B
    Contraception; 1982 May; 25(5):515-21. PubMed ID: 7105727
    [No Abstract]   [Full Text] [Related]  

  • 15. [Triquilar/Trinordiol. A new pill with 3 sequences].
    Obel EB
    Ugeskr Laeger; 1981 Jun; 143(25):1610-1. PubMed ID: 6795779
    [No Abstract]   [Full Text] [Related]  

  • 16. Observations with Ovidon.
    Farkas M; Falkay G; Szigethy A
    Ther Hung; 1977; 25(3):93-101. PubMed ID: 929481
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the interactions of ethynyl oestradiol and norgestrel.
    Edgren RA; Jones RC; Peterson DL; Gillen AL
    Acta Endocrinol (Copenh); 1967; 54():Suppl 115:3-21. PubMed ID: 6071573
    [No Abstract]   [Full Text] [Related]  

  • 18. Uterine response to prostaglandin e2 under oral contraceptives.
    Toppozada M; Khowessah M; Shaala S; Said S; Osman M
    Contraception; 1976 Jun; 13(6):749-61. PubMed ID: 1277847
    [No Abstract]   [Full Text] [Related]  

  • 19. [The menstrual cycle during Edival treatment. Results of a field study].
    Heithecker R; Laengner H
    ZFA (Stuttgart); 1979 Sep; 55(26):1455-6. PubMed ID: 483984
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum tsh and serum t3 levels during normal menstrual cycles and during cycles on oral contraceptives.
    Weeke J; Hansen AP
    Acta Endocrinol (Copenh); 1975 Jul; 79(3):431-8. PubMed ID: 1173500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.